Display options
Cite
Van Roy N, De Preter K, Hoebeeck J, et al. The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy. Genome Med. 2009;1(7):74doi: 10.1186/gm74.
Van Roy, N., De Preter, K., Hoebeeck, J., Van Maerken, T., Pattyn, F., Mestdagh, P., Vermeulen, J., Vandesompele, J., & Speleman, F. (2009). The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy. Genome medicine, 1(7), 74. https://doi.org/10.1186/gm74
Van Roy, Nadine, et al. "The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy." Genome medicine vol. 1,7 (2009): 74. doi: https://doi.org/10.1186/gm74
Van Roy N, De Preter K, Hoebeeck J, Van Maerken T, Pattyn F, Mestdagh P, Vermeulen J, Vandesompele J, Speleman F. The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy. Genome Med. 2009 Jul 27;1(7):74. doi: 10.1186/gm74. PMID: 19638189; PMCID: PMC2717400.
Copy Download .nbib Format: NLM
Share it on

Genome Med. 2009 Jul 27;1(7):74. doi: 10.1186/gm74.

The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Genome medicine

Nadine Van Roy, Katleen De Preter, Jasmien Hoebeeck, Tom Van Maerken, Filip Pattyn, Pieter Mestdagh, Joëlle Vermeulen, Jo Vandesompele, Frank Speleman

Affiliations

  1. Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium.

PMID: 19638189 PMCID: PMC2717400 DOI: 10.1186/gm74

Abstract

Neuroblastoma is one of the most common solid tumors of childhood, arising from immature sympathetic nervous system cells. The clinical course of patients with neuroblastoma is highly variable, ranging from spontaneous regression to widespread metastatic disease. Although the outcome for children with cancer has improved considerably during the past decades, the prognosis of children with aggressive neuroblastoma remains dismal. The clinical heterogeneity of neuroblastoma mirrors the biological and genetic heterogeneity of these tumors. Ploidy and MYCN amplification have been used as genetic markers for risk stratification and therapeutic decision making, and, more recently, gene expression profiling and genome-wide DNA copy number analysis have come into the picture as sensitive and specific tools for assessing prognosis. The applica tion of new genetic tools also led to the discovery of an important familial neuroblastoma cancer gene, ALK, which is mutated in approximately 8% of sporadic tumors, and genome-wide association studies have unveiled loci with risk alleles for neuroblastoma development. For some of the genomic regions that are deleted in some neuroblastomas, on 1p, 3p and 11q, candidate tumor suppressor genes have been identified. In addition, evidence has emerged for the contribution of epigenetic disturbances in neuroblastoma oncogenesis. As in other cancer entities, altered microRNA expression is also being recognized as an important player in neuroblastoma. The recent successes in unraveling the genetic basis of neuroblastoma are now opening opportunities for development of targeted therapies.

References

  1. Nucleic Acids Res. 2008 Jan;36(Database issue):D842-6 - PubMed
  2. Cancer Res. 2007 Feb 1;67(3):976-83 - PubMed
  3. Oncogene. 2003 Feb 20;22(7):1002-11 - PubMed
  4. Cancer Cell. 2009 Jan 6;15(1):67-78 - PubMed
  5. Nature. 2008 Oct 16;455(7215):930-5 - PubMed
  6. Oncogene. 2002 Mar 27;21(13):2097-101 - PubMed
  7. Cancer Res. 2008 May 1;68(9):3389-95 - PubMed
  8. Nat Genet. 2003 Apr;33(4):459-61 - PubMed
  9. Int J Cancer. 2008 Feb 1;122(3):699-704 - PubMed
  10. J Clin Oncol. 2005 Dec 1;23(34):8819-27 - PubMed
  11. N Engl J Med. 1999 Jun 24;340(25):1954-61 - PubMed
  12. J Natl Cancer Inst. 2006 Sep 6;98(17):1193-203 - PubMed
  13. Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2812-7 - PubMed
  14. J Clin Oncol. 2009 Jan 10;27(2):298-303 - PubMed
  15. Lancet Oncol. 2009 Jul;10(7):663-71 - PubMed
  16. Genes Chromosomes Cancer. 2007 Oct;46(10):936-49 - PubMed
  17. BMC Genomics. 2008 Jul 29;9:353 - PubMed
  18. J Clin Oncol. 2009 Jan 10;27(2):289-97 - PubMed
  19. Hum Hered. 2007;63(3-4):205-11 - PubMed
  20. Science. 1984 Jun 8;224(4653):1121-4 - PubMed
  21. J Clin Oncol. 2009 Mar 1;27(7):1026-33 - PubMed
  22. Clin Cancer Res. 2008 Jun 1;14(11):3248-53 - PubMed
  23. Cell Cycle. 2006 Oct;5(19):2191-4 - PubMed
  24. Med Res Rev. 2008 May;28(3):372-412 - PubMed
  25. J Natl Cancer Inst. 2003 Sep 17;95(18):1394-403 - PubMed
  26. Cancer Res. 2004 Oct 1;64(19):6883-91 - PubMed
  27. Nature. 2008 Oct 16;455(7215):975-8 - PubMed
  28. Nature. 2008 Oct 16;455(7215):971-4 - PubMed
  29. Clin Cancer Res. 2007 Jun 1;13(11):3191-7 - PubMed
  30. Int J Cancer. 2008 Mar 1;122(5):1177-82 - PubMed
  31. N Engl J Med. 2008 Jun 12;358(24):2585-93 - PubMed
  32. Science. 2004 Feb 6;303(5659):844-8 - PubMed
  33. Genes Chromosomes Cancer. 1994 Jun;10(2):103-14 - PubMed
  34. BMC Cancer. 2008 Jun 17;8:173 - PubMed
  35. PLoS One. 2008 May 21;3(5):e2236 - PubMed
  36. Carcinogenesis. 2004 Sep;25(9):1599-609 - PubMed
  37. Nature. 1984 Mar 15-21;308(5956):288-91 - PubMed
  38. Int J Cancer. 2007 Feb 1;120(3):533-8 - PubMed
  39. Genome Biol. 2008 Oct 13;9(10):R150 - PubMed
  40. Am J Hum Genet. 1972 Sep;24(5):514-32 - PubMed
  41. Am J Pathol. 2005 Jul;167(1):213-22 - PubMed
  42. Cell. 2007 Feb 9;128(3):459-75 - PubMed
  43. Mol Cancer Ther. 2006 Sep;5(9):2358-65 - PubMed
  44. Oncogene. 2005 Nov 24;24(53):7902-12 - PubMed
  45. Cancer Lett. 2009 Jan 18;273(2):336-46 - PubMed
  46. Cancer Res. 2006 Feb 15;66(4):2138-45 - PubMed
  47. Lancet Oncol. 2003 Aug;4(8):472-80 - PubMed
  48. J Natl Cancer Inst. 2004 Aug 18;96(16):1208-19 - PubMed
  49. Genes Chromosomes Cancer. 1996 Nov;17(3):156-65 - PubMed
  50. Clin Cancer Res. 2009 Jun 1;15(11):3690-6 - PubMed
  51. Nat Rev Cancer. 2006 Apr;6(4):259-69 - PubMed
  52. J Cell Biochem. 2009 May 1;107(1):46-57 - PubMed
  53. N Engl J Med. 1985 Oct 31;313(18):1111-6 - PubMed
  54. Eur J Cancer. 1997 Oct;33(12):1997-2001 - PubMed
  55. Nat Rev Cancer. 2002 Oct;2(10):740-9 - PubMed
  56. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):731-6 - PubMed
  57. Clin Cancer Res. 2008 Sep 1;14(17):5540-7 - PubMed
  58. Genes Chromosomes Cancer. 2001 Jul;31(3):228-39 - PubMed
  59. Lancet. 1998 Mar 21;351(9106):882-3 - PubMed
  60. Oncogene. 2007 Jul 26;26(34):5017-22 - PubMed
  61. J Clin Oncol. 1991 Apr;9(4):581-91 - PubMed
  62. Genes Chromosomes Cancer. 1998 Oct;23(2):141-52 - PubMed
  63. Biochem J. 2008 Dec 1;416(2):153-9 - PubMed
  64. PLoS One. 2008 May 21;3(5):e2207 - PubMed
  65. Genes Chromosomes Cancer. 2007 Dec;46(12):1098-108 - PubMed
  66. Am J Pathol. 2007 Apr;170(4):1370-8 - PubMed
  67. Nature. 2008 Oct 16;455(7215):967-70 - PubMed
  68. Nature. 2005 Jun 9;435(7043):839-43 - PubMed
  69. Med Pediatr Oncol. 2001 Jan;36(1):5-10 - PubMed
  70. Nat Rev Cancer. 2009 Jan;9(1):28-39 - PubMed
  71. J Natl Cancer Inst. 2008 Jul 2;100(13):940-9 - PubMed
  72. Nat Genet. 1996 Dec;14(4):430-40 - PubMed
  73. Genes Chromosomes Cancer. 1990 Sep;2(3):252-4 - PubMed
  74. Br J Cancer. 2001 Aug 17;85(4):531-7 - PubMed
  75. Br J Cancer. 2009 May 5;100(9):1471-82 - PubMed
  76. Cancer Cell. 2005 Apr;7(4):337-50 - PubMed
  77. Nature. 2005 Jun 9;435(7043):834-8 - PubMed
  78. Cancer Genet Cytogenet. 2000 Jul 1;120(1):44-9 - PubMed
  79. Cancer Res. 2005 Nov 1;65(21):9628-32 - PubMed
  80. Cancer Res. 2006 Oct 1;66(19):9646-55 - PubMed
  81. Nat Genet. 2009 Jun;41(6):718-23 - PubMed
  82. Oncogene. 1995 Mar 16;10(6):1087-93 - PubMed
  83. Br J Cancer. 2009 Jan 27;100(2):399-404 - PubMed
  84. Nat Rev Cancer. 2003 Mar;3(3):203-16 - PubMed
  85. Genes Chromosomes Cancer. 2001 Feb;30(2):168-74 - PubMed
  86. J Biol Chem. 2008 Sep 5;283(36):24426-34 - PubMed
  87. Genes Chromosomes Cancer. 1994 Aug;10(4):275-81 - PubMed
  88. Genes Chromosomes Cancer. 2001 Aug;31(4):326-32 - PubMed
  89. Cancer Cell. 2004 Dec;6(6):625-30 - PubMed
  90. Cancer Res. 2001 Jan 15;61(2):679-86 - PubMed
  91. Oncogene. 2008 Jan 31;27(6):803-10 - PubMed
  92. EMBO J. 1997 Jun 2;16(11):2985-95 - PubMed
  93. N Engl J Med. 2005 Nov 24;353(21):2243-53 - PubMed
  94. J Clin Oncol. 2005 Sep 20;23(27):6466-73 - PubMed
  95. Cancer Res. 1995 Nov 15;55(22):5366-9 - PubMed
  96. Prog Clin Biol Res. 1994;385:59-66 - PubMed
  97. Am J Hum Genet. 2004 Oct;75(4):727-30 - PubMed
  98. Lancet. 2007 Jun 23;369(9579):2106-20 - PubMed
  99. Int J Oncol. 2007 May;30(5):1189-96 - PubMed
  100. Pediatr Blood Cancer. 2004 Jan;42(1):99-105 - PubMed
  101. Cell Growth Differ. 1991 Oct;2(10):511-8 - PubMed
  102. J Clin Oncol. 2006 Nov 1;24(31):5070-8 - PubMed
  103. Cancer Res. 2009 Jan 15;69(2):416-21 - PubMed
  104. Am J Hum Genet. 1994 Aug;55(2):341-7 - PubMed
  105. Int J Cancer. 2008 Nov 1;123(9):2087-94 - PubMed
  106. Cancer Res. 2005 Feb 1;65(3):828-34 - PubMed
  107. Br J Cancer. 1998 Jun;77(11):1787-91 - PubMed
  108. Oncogene. 2008 May 22;27(23):3329-38 - PubMed
  109. Oncogene. 2005 Aug 25;24(36):5619-28 - PubMed
  110. Eur J Cancer. 2008 Nov;44(17):2634-9 - PubMed
  111. Genome Biol. 2006;7(9):R84 - PubMed
  112. Cancer Lett. 2003 Jul 18;197(1-2):125-30 - PubMed
  113. N Engl J Med. 1996 Jan 25;334(4):225-30 - PubMed
  114. Clin Cancer Res. 2008 Nov 1;14(21):7011-9 - PubMed
  115. Biochem Biophys Res Commun. 2006 Dec 8;351(1):192-7 - PubMed
  116. Cancer Cell. 2002 Nov;2(5):377-86 - PubMed
  117. Oncogene. 2008 Jan 17;27(4):441-9 - PubMed
  118. Int J Cancer. 2001 Mar 1;91(5):680-6 - PubMed
  119. Oncogene. 2005 Apr 14;24(16):2684-94 - PubMed
  120. Genes Chromosomes Cancer. 2000 Oct;29(2):89-95 - PubMed
  121. Am J Hum Genet. 1994 Aug;55(2):334-40 - PubMed
  122. Oncogene. 2008 Sep 4;27(39):5204-13 - PubMed
  123. Genes Chromosomes Cancer. 1994 May;10(1):30-9 - PubMed
  124. Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6344-9 - PubMed
  125. J Clin Oncol. 2005 Apr 1;23(10):2280-99 - PubMed
  126. Genes Chromosomes Cancer. 1994 Aug;10(4):231-43 - PubMed
  127. Science. 2006 Sep 29;313(5795):1929-35 - PubMed
  128. Genet Med. 2007 Sep;9(9):574-84 - PubMed
  129. Am J Hum Genet. 2004 Apr;74(4):761-4 - PubMed

Publication Types